Patent application number | Description | Published |
20080262056 | Oxindole Oxazolidinones as Antibacterial Agents - The present invention relates to novel oxazolidinones derivatives of oxindoles of formula I or a pharmaceutically acceptable salt thereof wherein: Y | 10-23-2008 |
20090137553 | Thiazepine Oxazolidinones as Antibacterial Agents - The present invention relates to a new class of oxazolidinone derivatives, to their use as antibacterial agents, to pharmaceutical compositions containing these compounds and to methods for their preparation. | 05-28-2009 |
20090149520 | OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS - The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein X is C | 06-11-2009 |
20090221655 | ANTIBACTERIAL AGENTS - The present invention provides a compound of Formula (I) Or a pharmaceutically acceptable salt thereof wherein: W is CH | 09-03-2009 |
20090318431 | BENZOXAZINONE AND BENZOXAZEPINONE OXAZOLIDINONES AS ANTIBACTERIAL AGENTS - The present invention provides a compound of formula (I) wherein X is a structure of the following formula (i), (ii) (iii), or iv G is O, or S; U is —(CR | 12-24-2009 |
20150038437 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE - The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens. | 02-05-2015 |
20150038438 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE - The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens. | 02-05-2015 |
20150080362 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE - The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens. | 03-19-2015 |